Follicular lymphoma grade IIIa, spleen
ICD-10 C82.37 is a billable code used to indicate a diagnosis of follicular lymphoma grade iiia, spleen.
Follicular lymphoma is a type of non-Hodgkin lymphoma characterized by the proliferation of follicle center (germinal center) B-cells. Grade IIIa indicates a more aggressive form of the disease, where there is a higher percentage of large cells present in the tumor. When this lymphoma affects the spleen, it can lead to splenomegaly and may present with systemic symptoms. Patients may experience B-symptoms, which include fever, night sweats, and weight loss. The diagnosis is typically confirmed through biopsy and histological examination, which reveals the characteristic follicular architecture. Staging of follicular lymphoma is crucial for determining the appropriate treatment approach, which may include watchful waiting, chemotherapy, immunotherapy, or stem cell transplantation, depending on the stage and symptoms. The prognosis varies based on the grade and stage of the lymphoma, with grade IIIa generally indicating a more aggressive disease course requiring prompt intervention.
Detailed pathology reports, treatment plans, and follow-up notes.
Diagnosis and management of newly diagnosed lymphoma, treatment response assessments.
Ensure accurate grading and staging are documented to support coding.
Comprehensive biopsy reports and histological findings.
Evaluation of lymph node and spleen biopsies for lymphoma diagnosis.
Pathology reports must clearly indicate the grade and type of lymphoma.
Used to monitor blood counts in patients with lymphoma.
Document the reason for the CBC and any relevant findings.
Hematology specialists should ensure correlation with lymphoma treatment.
Common treatments include chemotherapy regimens such as R-CHOP, immunotherapy with monoclonal antibodies, and in some cases, stem cell transplantation, depending on the patient's overall health and disease stage.
